Literature DB >> 17496430

Retinoblastoma protein prevents staurosporine-induced cell death in a retinoblastoma-defective human glioma cell line.

Fumiyuki Yamasaki1, Yoshinori Kajiwara, Seiji Hama, Taro Murakami, Toshikazu Hidaka, Taiichi Saito, Hiroyuki Yoshioka, Kazuhiko Sugiyama, Kazunori Arita, Kaoru Kurisu.   

Abstract

OBJECTIVE: To investigate the mechanism of staurosporine-induced glioma cell death and cell cycle arrest using adenovirus-mediated gene transfection, as well as the function of retinoblastoma (Rb) and genetic instability induced by staurosporine.
METHODS: Cell cycle regulation, cell death and nuclear abnormalities induced by staurosporine were examined using an adenovirus vector expressing Rb, p16 or p21 genes in human glioma cell lines.
RESULTS: The Rb-defective SF-539 cell line was resistant to staurosporine compared with cell lines expressing intact Rb. SF-539 glioma cells exposed to staurosporine became multinucleated and then died. Multinucleation was prevented in SF-539 cells transfected with the Rb gene, thus decreasing the death rate of these cells.
CONCLUSIONS: These results imply that enforced Rb expression protects cells from genomic instability induced by staurosporine regardless of its upstream molecular effects. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17496430     DOI: 10.1159/000101048

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  2 in total

1.  Sensitivity of breast cancer cells to erlotinib depends on cyclin-dependent kinase 2 activity.

Authors:  Fumiyuki Yamasaki; Dongwei Zhang; Chandra Bartholomeusz; Tamotsu Sudo; Gabriel N Hortobagyi; Kaoru Kurisu; Naoto T Ueno
Journal:  Mol Cancer Ther       Date:  2007-08-01       Impact factor: 6.261

2.  ColonyArea: an ImageJ plugin to automatically quantify colony formation in clonogenic assays.

Authors:  Camilo Guzmán; Manish Bagga; Amanpreet Kaur; Jukka Westermarck; Daniel Abankwa
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.